FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

208211000001102: Zyloric 300 tablets (GlaxoSmithKline) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16138301000001118 Zyloric 300 tablets (GlaxoSmithKline) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
69182501000001116 Zyloric 300mg tablets (Aspen Pharma Trading Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zyloric 300 tablets (GlaxoSmithKline) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zyloric 300 tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zyloric 300 tablets (GlaxoSmithKline) Is a Product containing precisely allopurinol 300 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Zyloric 300 tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zyloric 300 tablets (GlaxoSmithKline) Has excipient Lactose false Inferred relationship Existential restriction modifier
Zyloric 300 tablets (GlaxoSmithKline) Has active ingredient Allopurinol false Inferred relationship Existential restriction modifier
Zyloric 300 tablets (GlaxoSmithKline) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zyloric 300 tablets (GlaxoSmithKline) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zyloric 300 tablets (GlaxoSmithKline) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Zyloric 300 tablets (GlaxoSmithKline) Is a Zyloric true Inferred relationship Existential restriction modifier
Zyloric 300 tablets (GlaxoSmithKline) Has specific active ingredient Allopurinol true Inferred relationship Existential restriction modifier
Zyloric 300 tablets (GlaxoSmithKline) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Zyloric 300 tablets (GlaxoSmithKline) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zyloric 300 tablets (GlaxoSmithKline) 28 tablet 2 x 14 tablets Is pack of False Zyloric 300 tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Zyloric 300 tablets (GlaxoSmithKline) 28 tablet 2 x 14 tablets Has AMP True Zyloric 300 tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start